“There’s a lot of rhetoric in the air, and most of it nonproductive,” Mr. Ricks told CNBC. “We could cap [drug prices] forever. And what we get is less innovation and still have growing healthcare costs.”
Instead of capping drug prices, Mr. Ricks told CNBC he supports the bill from Senate Finance Committee that would add an out-of-pocket maximum for Medicare beneficiaries.
“We agree it’s time for change,” Mr. Ricks said. “We agree that patients need relief in the cost of medications.”
Read the full report here.
More articles on pharmacy:
Pfizer to merge off-patent business with Mylan
Senate panel advances drug-pricing legislation
Clinics leaving family planning program may have to toss thousands of dollars worth of drugs
